罗氏制药Roche-201405_Innovationandgrowth_By_CFO

InnovationandgrowthAlanHippe,CFORocheGroupBernsteinStrategicConference,May2014PerformanceupdateIndustryincontextBuildingpillarsofgrowthSummary2Q12014:Strongsalesgrowth3CER=ConstantExchangeRates20142013Changein%CHFbnCHFbnCHFCERPharmaceuticalsDivision9.09.2-14DiagnosticsDivision2.52.427RocheGroup11.511.6-15Q12014:BothDivisionsgrowinginallregions4012345JapanInternationalEuropeUSDiagnosticsPharma+3%+5%+1%+19%+3%+11%+7%+10%CHFbn+4%+5%+17%+3%Allgrowthratesatconstantexchangerates16.316.615.117.217.933.2%34.9%35.6%37.7%38.3%20092010201120122013+8%11AtconstantexchangeratesGroupoperatingprofitandmargin5CHFbn%ofsales2013:Dividendfurtherincreased67.800.001.002.003.004.005.006.007.008.001991199319951997199920012003